COMMUNIQUÉS West-GlobeNewswire

Virbac : chiffre d'affaires en croissance de +4,3% à taux de change constants au deuxième trimestre 2018
17/07/2018
CHIFFRES CLÉS Chiffre d'affaires du 1 er semestre 2018 - Provisoire 429,7 m€ Évolution globale -1,8% Croissance à taux de change constants +3,8% Croissance à change et périmètre constants 1 +3,8% dont animaux de [...]
The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2018 Cell & Gene Meeting on the Mesa
17/07/2018
WASHINGTON, DC, July 17, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative medicine sector, today [...]
GUERBET : Descriptif du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018
17/07/2018
Villepinte (France), le 17 juillet 2018 (17h00 heures CET) Le présent document a pour finalité de présenter le programme de rachat d'actions préalablement à sa réalisation, conformément aux dispositions de l'article 241 [...]
Tauriga Sciences Inc. Tenders One Time Cash Payment of $69,502.74 to GS Capital Partners LLC to Fully Repay and Retire the Remainder of the Outstanding Balance Pursuant to the October 17, 2017 $105,000 Face Value 8.00% Convertible Debenture
17/07/2018
NEW YORK, NY, July 17, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (OTC PINK: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Micron Products, Inc. Awarded U.S. Patent
17/07/2018
FITCHBURG, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc., a wholly owned subsidiary of Micron Solutions, Inc. (NYSE American:MICR), (together “Micron” or “the Company”) announces today that the Company [...]
Rubicon Organics™ Capitalizes on the Organic Movement -- CFN Media
17/07/2018
SEATTLE, WA, July 17, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article that [...]
GeneriCo, LLC Completes Transaction
17/07/2018
ST. LOUIS, July 17, 2018 (GLOBE NEWSWIRE) -- GeneriCo, LLC (GeneriCo), a specialty generic drug company, today announced that it completed a deal transaction with a leading US generic pharmaceutical company for the [...]
Canopy’s $350M Hiku Acquisition Underscores the Value of Cannabis Brands -- CFN Media
17/07/2018
SEATTLE, July 17, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Advanced Proteome Therapeutics Announces Collaboration with Noria Pharmaceuticals
17/07/2018
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8), is pleased to announce the collaboration of APC with Noria [...]
NSS Labs Announces 2018 Next Generation Firewall Group Test Results
17/07/2018
7 products receive Recommended Rating; 1 product receives Security Recommended Rating; and 2 products receive Caution rating AUSTIN, Texas, July 17, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted [...]
MPX Secures Final Approval to Open First Managed Dispensary in Maryland; Schedules Grand Opening for August 4th
17/07/2018
Production of MPX-branded cannabis to commence at managed facility as Company’s Maryland expansion strategy ramps up TORONTO, July 17, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) ( [...]
Canada House Wellness Group Enters into Exclusive Licensing Agreement with Medicine Man Technologies for Canadian Deployment of its Intellectual Property and Product Lines
17/07/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 17, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (" Canada House ") or the (" Company ") (CSE:CHV) is [...]
CV Sciences, Inc. Expands Retail Store Count of its Industry-Dominating Brand, PlusCBD Oil,™ in the Natural Products Industry
17/07/2018
Company’s Ongoing Strategic Efforts to Mainstream Hemp CBD Products Continue to Prove Successful in Capturing New independent Health Food Store Accounts LAS VEGAS, July 17, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. ( [...]
Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria
17/07/2018
Sale of Assets Transforms Scythian Into a Highly Liquid and Well Capitalized Company with Over $200 million in Cash and Marketable Securities on Hand Allows for Additional Transactions in Line with Scythian's Strategic [...]
Zosano Announces Positive Data from a Nonclinical Evaluation of Pharmacokinetics and Skin Tolerability Study for ADAM™ Technology for the Delivery of Zolmitriptan
17/07/2018
Peer-reviewed article published in Journal of Pharmaceutical Science evaluates skin tolerability and bioavailability of ADAM’s intracutaneous zolmitriptan delivery FREMONT, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- [...]
Avivagen Chairman and CEO Kym Anthony, Joins Everett Jolly Uptick Newswire’s “Stock Day” Podcast
17/07/2018
PHOENIX, July 17, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire, today announced the interview of Avivagen Chairman and CEO Kym Anthony on Stock Day Podcast with Everett Jolly. Avivagen’s scientifically backed, evidence- [...]
Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 2018
17/07/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second [...]
Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer
17/07/2018
-- Senior Executive with Extensive Financial Leadership Experience Further Strengthens Management Team; Company Also Adds Senior Director of Business Development for Western Region to Support Client Acquisition Efforts [...]
Samumed to Present Preclinical Data on SM07883, a Potential First-in-Class Alzheimer’s Disease Candidate, at the Alzheimer’s Association International Conference® (AAIC®) 2018
17/07/2018
SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has been selected to present preclinical data on the company’s novel DYRK1a inhibitor, SM07883, a potential first-in-class drug for the [...]

Pages